739366-20-2,MFCD19443729
Catalog No.:AA00FBYL

739366-20-2 | Anagliptin

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$63.00   $44.00
- +
5mg
≥95%
in stock  
$268.00   $187.00
- +
10mg
≥95%
in stock  
$502.00   $351.00
- +
250mg
95%
in stock  
$884.00   $619.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FBYL
Chemical Name:
Anagliptin
CAS Number:
739366-20-2
Molecular Formula:
C19H25N7O2
Molecular Weight:
383.4475
MDL Number:
MFCD19443729
SMILES:
N#C[C@@H]1CCCN1C(=O)CNC(CNC(=O)c1cnc2n(c1)nc(c2)C)(C)C
Properties
Computed Properties
 
Complexity:
643  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0  

Downstream Synthesis Route
739364-95-5   
(S)-1-(2-amino-1,1-dimethylethyl)aminoacetylpyrrolidine-2-carbonitriledihydrochloride 
 
(S)-2-methylpyrazolo1,5-apyrimidine-6-carboxylicacid{2-(2-cyanopyrrolidin-1-yl)-2-oxoethylamino-2-methylpropyl}amide 

[1]Patent:CN105399742,2016,A.Locationinpatent:Paragraph0050;0051;0052;0053;0058;0059;0060

[2]Patent:WO2015/104602,2015,A3.Locationinpatent:Page/Pagecolumn30

[1]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3Locationinpatent:Page/Pagecolumn31

[2]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0050

[1]Yan,Xin;Bain,RyanM.;Li,Yafeng;Qiu,Ran;Flick,TawnyaG.;Cooks,R.Graham[OrganicProcessResearchandDevelopment,2016,vol.20,#5,p.940-947]

[2]CurrentPatentAssignee:HAIMENBAIKANGPHARMACEUTICAL-CN105503878,2016,A

[3]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3

[1]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0051

Literature

Title: Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor.

Journal: Bioorganic & medicinal chemistry 20111201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 739366-20-2
Tags:739366-20-2 Molecular Formula|739366-20-2 MDL|739366-20-2 SMILES|739366-20-2 Anagliptin
Catalog No.: AA00FBYL
739366-20-2,MFCD19443729
739366-20-2 | Anagliptin
Pack Size: 1mg
Purity: ≥95%
in stock
$63.00 $44.00
Pack Size: 5mg
Purity: ≥95%
in stock
$268.00 $187.00
Pack Size: 10mg
Purity: ≥95%
in stock
$502.00 $351.00
Pack Size: 250mg
Purity: 95%
in stock
$884.00 $619.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FBYL
Chemical Name: Anagliptin
CAS Number: 739366-20-2
Molecular Formula: C19H25N7O2
Molecular Weight: 383.4475
MDL Number: MFCD19443729
SMILES: N#C[C@@H]1CCCN1C(=O)CNC(CNC(=O)c1cnc2n(c1)nc(c2)C)(C)C
Properties
Complexity: 643  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0  
Downstream Synthesis Route
739364-95-5   
(S)-1-(2-amino-1,1-dimethylethyl)aminoacetylpyrrolidine-2-carbonitriledihydrochloride 
 
(S)-2-methylpyrazolo1,5-apyrimidine-6-carboxylicacid{2-(2-cyanopyrrolidin-1-yl)-2-oxoethylamino-2-methylpropyl}amide 

[1]Patent:CN105399742,2016,A.Locationinpatent:Paragraph0050;0051;0052;0053;0058;0059;0060

[2]Patent:WO2015/104602,2015,A3.Locationinpatent:Page/Pagecolumn30

739366-20-2    1359670-56-6 

[1]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3Locationinpatent:Page/Pagecolumn31

[2]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0050

739365-95-8    739366-20-2 

[1]Yan,Xin;Bain,RyanM.;Li,Yafeng;Qiu,Ran;Flick,TawnyaG.;Cooks,R.Graham[OrganicProcessResearchandDevelopment,2016,vol.20,#5,p.940-947]

[2]CurrentPatentAssignee:HAIMENBAIKANGPHARMACEUTICAL-CN105503878,2016,A

[3]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3

739366-20-2    104-15-4    1567838-27-0 

[1]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0051

Literature fold

Title: Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor.

Journal: Bioorganic & medicinal chemistry20111201

Building Blocks More >
660417-22-1
660417-22-1
4-Cyclopropyl-5-(thiophen-2-yl)-4H-1,2,4-triazole-3-thiol
AA00FC39 | MFCD06655863
676515-33-6
676515-33-6
1,8-Naphthyridin-4(1H)-one,2,3-dihydro-(9CI)
AA00FCAI | MFCD09834135
72798-66-4
72798-66-4
1-(2-PROPENYL)-2-BENZIMIDAZOLIDINONE
AA00FCKA | MFCD00218253
664338-39-0
664338-39-0
Arterolane
AA00FCU9 | MFCD18251543
683772-11-4
683772-11-4
4-(Pyrrolidin-1-ylmethyl)piperidine dihydrochloride
AA00FD0Q | MFCD05215177
685892-12-0
685892-12-0
4-IODOBENZOYLTRIFLUOROACETONE
AA00FD5C | MFCD03789130
74075-34-6
74075-34-6
Vinorelbine N'b-Oxide Sulfate Salt
AA00FDAK
661463-79-2
661463-79-2
LaMotrigine IMpurity D
AA00FDJC | MFCD27967276
680622-70-2
680622-70-2
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE
AA00FDRN | MFCD09841373
676135-95-8
676135-95-8
(S)-7-Bromo-1,2,3,4-tetrahydro-naphthalen-1-ylamine
AA00FE0N | MFCD07374013
Submit
© 2017 AA BLOCKS, INC. All rights reserved.